U.S. Markets open in 1 hr 15 mins

Syndax: 3Q Earnings Snapshot

WALTHAM, Mass. (AP) _ Syndax Pharmaceuticals Inc. (SNDX) on Thursday reported a loss of $12.8 million in its third quarter.

On a per-share basis, the Waltham, Massachusetts-based company said it had a loss of 41 cents.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 48 cents per share.

The biopharmaceutical company posted revenue of $379,000 in the period.

Syndax shares have increased 56% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $6.96, a climb of 29% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SNDX at https://www.zacks.com/ap/SNDX